Literature DB >> 2332123

Increased risk of cerebral palsy among very low-birthweight infants with chronic lung disease.

M D Skidmore1, A Rivers, M Hack.   

Abstract

To determine the risk of cerebral palsy and other forms of neurosensory impairment in very low-birthweight infants (less than 1500g) with severe lung disease, as compared with those with lesser degrees of lung disease, and to examine perinatal and demographic correlates of chronic lung disease, the authors prospectively followed 249 survivors born between 1983 and 1984. 52 (21 per cent) developed chronic lung disease (CLD), defined as oxygen dependence greater than or equal to 28 days. 15 per cent of children with CLD developed cerebral palsy, compared with 3 per cent who required oxygen for between three and 27 days and 4 per cent of those requiring oxygen for two days or less. The overall neurological impairment rate, including cerebral palsy, abnormalities of muscle tone, hydrocephalus requiring a shunt, and severe visual or hearing impairment, was 29 per cent for infants with CLD. This compares with rates of 9 per cent for those requiring oxygen for between three and 27 days and 6 per cent for those on oxygen for two or less days. Infants with CLD had a significantly lower mean birthweight and gestational age; 43 per cent had grade III or IV intraventricular hemorrhages; and they also required longer periods in hospital.

Entities:  

Mesh:

Year:  1990        PMID: 2332123     DOI: 10.1111/j.1469-8749.1990.tb16944.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  19 in total

1.  Follow up of a randomised trial of two different courses of dexamethasone for preterm babies at risk of chronic lung disease.

Authors:  D L Armstrong; J Penrice; F H Bloomfield; D B Knight; J A Dezoete; J E Harding
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-03       Impact factor: 5.747

Review 2.  Chronic lung disease in the preterm infant. Lessons learned from animal models.

Authors:  Anne Hilgendorff; Irwin Reiss; Harald Ehrhardt; Oliver Eickelberg; Cristina M Alvira
Journal:  Am J Respir Cell Mol Biol       Date:  2014-02       Impact factor: 6.914

3.  Prenatal predictors of chronic lung disease in very preterm infants.

Authors:  D J Henderson-Smart; J L Hutchinson; D A Donoghue; N J Evans; J M Simpson; I Wright
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-08-30       Impact factor: 5.747

4.  Volume guarantee pressure support ventilation in extremely preterm infants and neurodevelopmental outcome at 18 months.

Authors:  B M Stefanescu; N Frewan; J C Slaughter; T M O'Shea
Journal:  J Perinatol       Date:  2015-01-08       Impact factor: 2.521

5.  Early motor and mental development in very preterm infants with chronic lung disease.

Authors:  M Katz-Salamon; E M Gerner; B Jonsson; H Lagercrantz
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-07       Impact factor: 5.747

6.  A longitudinal study of developmental outcome of infants with bronchopulmonary dysplasia and very low birth weight.

Authors:  L Singer; T Yamashita; L Lilien; M Collin; J Baley
Journal:  Pediatrics       Date:  1997-12       Impact factor: 7.124

7.  Respiratory Support for Very Low Birth Weight Infants Receiving Dexamethasone.

Authors:  Yamini V Virkud; Christoph P Hornik; Daniel K Benjamin; Matthew M Laughon; Reese H Clark; Rachel G Greenberg; P Brian Smith
Journal:  J Pediatr       Date:  2017-01-18       Impact factor: 4.406

Review 8.  Current perspectives on the prevention and management of chronic lung disease in preterm infants.

Authors:  Prakesh S Shah
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

9.  Nasal continuous positive airway pressure and outcomes in preterm infants: A retrospective analysis.

Authors:  Gustavo Pelligra; Mohamed A Abdellatif; Shoo K Lee
Journal:  Paediatr Child Health       Date:  2008-02       Impact factor: 2.253

Review 10.  Intra-amniotic surfactant for women at risk of preterm birth for preventing respiratory distress in newborns.

Authors:  Mohamed E Abdel-Latif; David A Osborn; Daniel Challis
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.